Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
105 words
In a process for the preparation of a porous carrier material containing an immuno-reactive first component by application to said carrier material of a solution of said first component and a solution of a second component which immuno-precipitates said first component without perturbing the immuno-reactivity of said first component, and subsequent drying of the carrier material impregnated with said immuno-precipitated first component, wherein the improvement comprises the steps of impregnating said carrier material with a solution of said first and second components plus an inhibitor of the immuno-precipitation reaction, and initiating said immuno-precipitation by removal of said inhibitor or by neutralization of its inhibiting action.
Claim 2
Dependent Claim
105 words
In a process for the preparation of a porous carrier material containing an immuno-reactive first component by application to said carrier material of a solution of said first component and a solution of a second component which immuno-precipitates said first component without perturbing the immuno-reactivity of said first component, and subsequent drying of the carrier material impregnated with said immuno-precipitated first component, wherein the improvement comprises the steps of impregnating said carrier material with a solution of said first and second components plus an inhibitor of the immuno-precipitation reaction, and initiating said immuno-precipitation by removal of said inhibitor or by neutralization of its inhibiting action.
Claim 3
Dependent Claim
26 words
Process according to claim 1, wherein the components of the immuno-precipitation reaction are a protein and an antibody or a fragment thereof directed against this protein.
Claim 4
Dependent Claim
18 words
Process according to claim 2, wherein a protein is used to which a hapten or antigen is coupled.
Claim 5
Dependent Claim
33 words
Process according to claim 2, wherein one of said components is an antibody or a fragment thereof directed against the protein to which antibody or fragment thereof is coupled a hapten or antigen.
Claim 6
Dependent Claim
13 words
Process according to claim 2, wherein a specific antibody is used as protein.
Claim 7
Dependent Claim
14 words
Process according to claim 1 wherein the inhibitor is an acid or a base.
Claim 8
Dependent Claim
23 words
Process according to claim 4, wherein the inhibitor is a volatile acid or base and the removal of the inhibitor is by evaporation.
Claim 9
Dependent Claim
33 words
Process according to claim 6, wherein the inhibitor is is a non-volatile acid or base and a carrier material is employed which is impregnated with a salt of a volatile acid or base.
Claim 10
Dependent Claim
36 words
Process according to claim 1 wherein the inhibitor is glycerol or urea and, after impregnation of the carrier material, the inhibitor is removed by extraction with a mixture of at least one organic solvent and water.
Claim 11
Dependent Claim
29 words
Process according to claim 1 wherein the inhibitor is a metal salt, the inhibiting action of which in the carrier material is neutralized by means of a complex former.
Claim 12
Dependent Claim
16 words
Process according to claim 1 wherein the inhibitor is a chaotropic ion of the Hofmeister series.
Claim 13
Dependent Claim
11 words
Process according to claim 11, wherein the inhibitor is a thiocyanate.
Claim 14
Dependent Claim
13 words
Process according to claim 11, wherein the inhibitor is an alkali metal iodide.
Claim 15
Dependent Claim
24 words
Process according to claim 1 wherein the first and second components of the immuno-precipitation reaction are used in the ratio of the Heidelberger maximum.
Claim 16
Dependent Claim
19 words
Process according to claim 1 wherein at least one component of the immuno-precipitation reaction is used in non-purified form.
Claim 17
Dependent Claim
43 words
Process according to claim 1 wherein the solution of both components of the immuno-precipitation reaction is first prepared as a suspension precipitate which, after washing, is dissolved by the addition of an inhibitor and subsequently used for the impregnation of the porous carrier.
Claim 18
Dependent Claim
21 words
The process of claim 11, wherein the improvement comprises the further step of washing said carrier material containing immuno-precipitated first component.